Advertisement
Screener

Zoetis Inc. (ZTS) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Zoetis Inc. Investing Cash Flow

Zoetis Inc. (ZTS) reported Investing Cash Flow of -$387.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06

  • Zoetis Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$300.00M.
  • Zoetis Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$87.00M.
  • Zoetis Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$166.00M, a 231.75% decline year-over-year.
  • Zoetis Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$167.00M.
  • Zoetis Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$748.00M.
  • Zoetis Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$315.00M.
  • Zoetis Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$777.00M.
  • Zoetis Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$883.00M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 3 month as first filedNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 6 month as first filedNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$300.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$387.00M
10-Q · filed 2026-08-06
-$553.00M
derived: sum of 3 quarters · filed 2026-08-06
-$720.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$87.00M
10-Q · filed 2026-05-07
-$253.00M
derived: sum of 2 quarters · filed 2026-05-07
-$420.00M
derived: sum of 3 quarters · filed 2026-05-07
-$632.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$166.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$333.00M
derived: sum of 2 quarters · filed 2026-02-12
-$545.00M
derived: sum of 3 quarters · filed 2026-08-06
-$748.00M
10-K · filed 2026-02-12
2025-09-30-$167.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$379.00M
derived: sum of 2 quarters · filed 2026-08-06
-$582.00M
10-Q · filed 2025-11-04
-$456.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$212.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$415.00M
10-Q · filed 2026-08-06
-$422.00M
10-Q · filed 2025-08-05
-$289.00M
derived: sum of 3 quarters · filed 2026-08-06
-$467.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$203.00M
10-Q · filed 2026-05-07
-$175.00M
10-Q · filed 2025-05-06
-$77.00M
derived: sum of 2 quarters · filed 2026-05-07
-$255.00M
derived: sum of 3 quarters · filed 2026-05-07
-$387.00M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$126.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$52.00M
derived: sum of 2 quarters · filed 2026-02-12
-$184.00M
derived: sum of 3 quarters · filed 2026-02-12
-$315.00M
10-K · filed 2026-02-12
2024-09-30-$178.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$310.00M
derived: sum of 2 quarters · filed 2025-11-04
-$441.00M
10-Q · filed 2025-11-04
-$651.00M
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30-$132.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
-$263.00M
10-Q · filed 2025-08-05
-$473.00M
derived: sum of 3 quarters · filed 2026-02-12
-$744.00M
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31-$131.00M
10-Q · filed 2025-05-06
-$341.00M
derived: sum of 2 quarters · filed 2026-02-12
-$612.00M
derived: sum of 3 quarters · filed 2026-02-12
-$692.00M
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31-$210.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$481.00M
derived: sum of 2 quarters · filed 2026-02-12
-$561.00M
derived: sum of 3 quarters · filed 2026-02-12
-$777.00M
10-K · filed 2026-02-12
2023-09-30-$271.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
-$351.00M
derived: sum of 2 quarters · filed 2024-11-04
-$567.00M
10-Q · filed 2024-11-04
-$1.00B
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30-$80.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$296.00M
10-Q · filed 2024-08-06
-$734.00M
derived: sum of 3 quarters · filed 2025-02-13
-$858.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31-$216.00M
10-Q · filed 2024-05-02
-$654.00M
derived: sum of 2 quarters · filed 2025-02-13
-$778.00M
derived: sum of 3 quarters · filed 2025-02-13
-$981.00M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31-$438.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
-$562.00M
derived: sum of 2 quarters · filed 2025-02-13
-$765.00M
derived: sum of 3 quarters · filed 2025-02-13
-$883.00M
10-K · filed 2025-02-13
2022-09-30-$124.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$327.00M
derived: sum of 2 quarters · filed 2023-11-02
-$445.00M
10-Q · filed 2023-11-02
-$587.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-06-30-$203.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$321.00M
10-Q · filed 2023-08-08
-$463.00M
derived: sum of 3 quarters · filed 2024-02-13
-$577.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-03-31-$118.00M
10-Q · filed 2023-05-04
-$260.00M
derived: sum of 2 quarters · filed 2024-02-13
-$374.00M
derived: sum of 3 quarters · filed 2024-02-13
-$513.00M
derived: sum of 4 quarters · filed 2024-02-13
2021-12-31-$142.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13
-$256.00M
derived: sum of 2 quarters · filed 2024-02-13
-$395.00M
derived: sum of 3 quarters · filed 2024-02-13
-$458.00M
10-K · filed 2024-02-13
2021-09-30-$114.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$253.00M
derived: sum of 2 quarters · filed 2022-11-03
-$316.00M
10-Q · filed 2022-11-03
-$493.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30-$139.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$202.00M
10-Q · filed 2022-08-04
-$379.00M
derived: sum of 3 quarters · filed 2023-02-14
-$553.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31-$63.00M
10-Q · filed 2022-05-05
-$240.00M
derived: sum of 2 quarters · filed 2023-02-14
-$414.00M
derived: sum of 3 quarters · filed 2023-02-14
-$578.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31-$177.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
-$351.00M
derived: sum of 2 quarters · filed 2023-02-14
-$515.00M
derived: sum of 3 quarters · filed 2023-02-14
-$572.00M
10-K · filed 2023-02-14
2020-09-30-$174.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$338.00M
derived: sum of 2 quarters · filed 2021-11-04
-$395.00M
10-Q · filed 2021-11-04
-$608.00M
derived: sum of 4 quarters · filed 2022-02-15
2020-06-30-$164.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$221.00M
10-Q · filed 2021-08-05
-$434.00M
derived: sum of 3 quarters · filed 2022-02-15
-$643.00M
derived: sum of 4 quarters · filed 2022-02-15
2020-03-31-$57.00M
10-Q · filed 2021-05-06
-$270.00M
derived: sum of 2 quarters · filed 2022-02-15
-$479.00M
derived: sum of 3 quarters · filed 2022-02-15
-$538.00M
derived: sum of 4 quarters · filed 2022-02-15
2019-12-31-$213.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15
-$422.00M
derived: sum of 2 quarters · filed 2022-02-15
-$481.00M
derived: sum of 3 quarters · filed 2022-02-15
-$504.00M
10-K · filed 2022-02-15
2019-09-30-$209.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$268.00M
derived: sum of 2 quarters · filed 2020-11-05
-$291.00M
10-Q · filed 2020-11-05
-$365.00M
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30-$59.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$82.00M
10-Q · filed 2020-08-06
-$156.00M
derived: sum of 3 quarters · filed 2021-02-16
-$2.22B
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31-$23.00M
10-Q · filed 2020-05-06
-$97.00M
derived: sum of 2 quarters · filed 2021-02-16
-$2.16B
derived: sum of 3 quarters · filed 2021-02-16
-$2.24B
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31-$74.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
-$2.14B
derived: sum of 2 quarters · filed 2021-02-16
-$2.21B
derived: sum of 3 quarters · filed 2021-02-16
-$2.26B
10-K · filed 2021-02-16
2018-09-30-$2.06B
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$2.14B
derived: sum of 2 quarters · filed 2019-11-07
-$2.19B
10-Q · filed 2019-11-07
-$2.24B
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30-$76.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$121.00M
10-Q · filed 2019-08-06
-$175.00M
derived: sum of 3 quarters · filed 2020-02-13
-$303.00M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31-$45.00M
10-Q · filed 2019-05-02
-$99.00M
derived: sum of 2 quarters · filed 2020-02-13
-$227.00M
derived: sum of 3 quarters · filed 2020-02-13
-$267.00M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31-$54.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
-$182.00M
derived: sum of 2 quarters · filed 2020-02-13
-$222.00M
derived: sum of 3 quarters · filed 2020-02-13
-$270.00M
10-K · filed 2020-02-13
2017-10-01-$128.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
-$168.00M
derived: sum of 2 quarters · filed 2018-11-01
-$216.00M
10-Q · filed 2018-11-01
-$275.00M
derived: sum of 4 quarters · filed 2019-02-14
2017-07-02-$40.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$88.00M
10-Q · filed 2018-08-02
-$147.00M
derived: sum of 3 quarters · filed 2019-02-14
-$271.00M
derived: sum of 4 quarters · filed 2019-02-14
2017-04-02-$48.00M
10-Q · filed 2018-05-02
-$107.00M
derived: sum of 2 quarters · filed 2019-02-14
-$231.00M
derived: sum of 3 quarters · filed 2019-02-14
-$280.00M
derived: sum of 4 quarters · filed 2019-02-14
2016-12-31-$59.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14
-$183.00M
derived: sum of 2 quarters · filed 2019-02-14
-$232.00M
derived: sum of 3 quarters · filed 2019-02-14
-$214.00M
10-K · filed 2019-02-14
2016-10-02-$124.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$173.00M
derived: sum of 2 quarters · filed 2017-11-02
-$155.00M
10-Q · filed 2017-11-02
-$892.00M
derived: sum of 4 quarters · filed 2018-02-15
2016-07-03-$49.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$31.00M
10-Q · filed 2017-08-08
-$768.00M
derived: sum of 3 quarters · filed 2018-02-15
-$828.00M
derived: sum of 4 quarters · filed 2018-02-15
2016-04-03$18.00M
10-Q · filed 2017-05-04
-$719.00M
derived: sum of 2 quarters · filed 2018-02-15
-$779.00M
derived: sum of 3 quarters · filed 2018-02-15
-$823.00M
derived: sum of 4 quarters · filed 2018-02-15
2015-12-31-$737.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15
-$797.00M
derived: sum of 2 quarters · filed 2018-02-15
-$841.00M
derived: sum of 3 quarters · filed 2018-02-15
-$1.11B
10-K · filed 2018-02-15
2015-09-27-$60.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$104.00M
derived: sum of 2 quarters · filed 2016-11-03
-$378.00M
10-Q · filed 2016-11-03
-$428.00M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-28-$44.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
-$318.00M
10-Q · filed 2016-08-05
-$368.00M
derived: sum of 3 quarters · filed 2017-02-16
-$410.00M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-29-$274.00M
10-Q · filed 2016-05-06
-$324.00M
derived: sum of 2 quarters · filed 2017-02-16
-$366.00M
derived: sum of 3 quarters · filed 2017-02-16
-$416.00M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31-$50.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
-$92.00M
derived: sum of 2 quarters · filed 2017-02-16
-$142.00M
derived: sum of 3 quarters · filed 2017-02-16
-$187.00M
10-K · filed 2017-02-16
2014-09-28-$42.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$92.00M
derived: sum of 2 quarters · filed 2015-11-05
-$137.00M
10-Q · filed 2015-11-05
-$188.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-29-$50.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$95.00M
10-Q · filed 2015-08-06
-$146.00M
derived: sum of 3 quarters · filed 2016-02-24
-$200.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-30-$45.00M
10-Q · filed 2015-05-07
-$96.00M
derived: sum of 2 quarters · filed 2016-02-24
-$150.00M
derived: sum of 3 quarters · filed 2016-02-24
-$202.00M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31-$51.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
-$105.00M
derived: sum of 2 quarters · filed 2016-02-24
-$157.00M
derived: sum of 3 quarters · filed 2016-02-24
-$179.00M
10-K · filed 2016-02-24
2013-09-29-$54.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$106.00M
derived: sum of 2 quarters · filed 2014-11-10
-$128.00M
10-Q · filed 2014-11-10
-$174.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$52.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
-$74.00M
10-Q · filed 2014-08-12
-$120.00M
derived: sum of 3 quarters · filed 2015-02-27
-$150.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31-$22.00M
10-Q · filed 2014-05-13
-$68.00M
derived: sum of 2 quarters · filed 2015-02-27
-$98.00M
derived: sum of 3 quarters · filed 2015-02-27
-$124.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$46.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
-$76.00M
derived: sum of 2 quarters · filed 2015-02-27
-$102.00M
derived: sum of 3 quarters · filed 2015-02-27
-$135.00M
10-K · filed 2015-02-27
2012-09-30-$30.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
-$56.00M
derived: sum of 2 quarters · filed 2013-11-13
-$89.00M
10-Q · filed 2013-11-13
2012-07-01-$26.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$59.00M
10-Q · filed 2013-08-14
2012-04-01-$33.00M
10-Q · filed 2013-05-15
2011-12-31-$449.00M
10-K · filed 2014-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10